These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25862281)

  • 1. Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium.
    Zeller MP; Al-Habsi KS; Golder M; Walsh GM; Sheffield WP
    Transfus Med Rev; 2015 Jul; 29(3):181-94. PubMed ID: 25862281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of frozen transfusable plasma prepared from whole blood donations in Canada: an update.
    Sheffield WP; Bhakta V; Talbot K; Pryzdial EL; Jenkins C
    Transfus Apher Sci; 2013 Dec; 49(3):440-6. PubMed ID: 23849252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care.
    Klages M; Zacharowski K; Weber CF
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):245-9. PubMed ID: 26784352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supportive transfusion therapy in cancer patients with acquired defects of hemostasis.
    Federici AB; Intini D; Lattuada A; Vanelli C; Arrigoni L; Sacchi E; Russo U
    Thromb Res; 2014 May; 133 Suppl 2():S56-62. PubMed ID: 24862147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-hospital transfusion of plasma in hemorrhaging trauma patients independently improves hemostatic competence and acidosis.
    Henriksen HH; Rahbar E; Baer LA; Holcomb JB; Cotton BA; Steinmetz J; Ostrowski SR; Stensballe J; Johansson PI; Wade CE
    Scand J Trauma Resusc Emerg Med; 2016 Dec; 24(1):145. PubMed ID: 27938373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of drug-induced anticoagulation: old solutions and new problems.
    Dzik WS
    Transfusion; 2012 May; 52 Suppl 1():45S-55S. PubMed ID: 22578371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for plasma in massive transfusion.
    Hellstern P; Haubelt H
    Thromb Res; 2002 Oct; 107 Suppl 1():S19-22. PubMed ID: 12379288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophilia management in transfusion medicine.
    Poon MC; Card R
    Transfus Apher Sci; 2012 Jun; 46(3):299-307. PubMed ID: 22503305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
    Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
    Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trauma-associated bleeding: management of massive transfusion.
    Stephens CT; Gumbert S; Holcomb JB
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):250-5. PubMed ID: 26836808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.
    Desborough M; Stanworth S
    Transfusion; 2012 May; 52 Suppl 1():20S-9S. PubMed ID: 22578367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From plasma transfusion to individualized, goal-directed coagulation factor administration.
    Spahn DR
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S16-9. PubMed ID: 23910532
    [No Abstract]   [Full Text] [Related]  

  • 15. Low hemorrhage-related mortality in trauma patients in a Level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets.
    Johansson PI; Sørensen AM; Larsen CF; Windeløv NA; Stensballe J; Perner A; Rasmussen LS; Ostrowski SR
    Transfusion; 2013 Dec; 53(12):3088-99. PubMed ID: 23614333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Application of Prothrombin Complex Concentrate in Blood Management in Patients.
    Ozawa S; Nelson T
    Crit Care Nurse; 2017 Apr; 37(2):49-56. PubMed ID: 28365649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Transfusion Ratios in Massive Transfusion Protocols: An Argument Against the 1:1:1 Dogma and Approach to Trauma Resuscitation.
    Gregory JA; Huitron SS; George AA; Simon CD
    Lab Med; 2015; 46(2):e46-52. PubMed ID: 26169658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism.
    Magee G; Peters C; Zbrozek A
    Clin Ther; 2013 Sep; 35(9):1432-43. PubMed ID: 23954093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for prothrombin complex concentrates in massive transfusions.
    Blauhut B
    Thromb Res; 1999 Aug; 95(4 Suppl 1):S63-9. PubMed ID: 10499911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.